Showing results (191-200 of 242) with videos related to

Sort By:
Pageof 25
Science Translational Medicine|September 6, 2019
In vivo detection of cerebral tau pathology in long-term survivors of traumatic brain injuryNikos Gorgoraptis, Lucia M Li, Alex Whittington, et al.
Journal of Geriatric Psychiatry and Neurology|May 1, 2010
Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controlsD P Devanand, Arthur Mikhno, Gregory H Pelton, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2009
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studiesIdriss Bennacef, Cristian A Salinas, Thomas A Bonasera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2021
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory CancerSeung Tae Kim, Simon A Smith, Peter Mortimer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I StudyTimothy A Yap, Matthew G Krebs, Sophie Postel-Vinay, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 29, 2022
A Visual Interpretation Algorithm for Assessing Brain Tauopathy with 18F-MK-6240 PETJohn P Seibyl, Jonathan M DuBois, Annie Racine, et al.
Molecular Imaging|February 1, 2023
Evaluation of Intraperitoneal [18F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis CapacityEls F Halff, Sridhar Natesan, David R Bonsall, et al.
Journal of Alzheimer'S Disease : JAD|April 5, 2018
Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot StudyRíona Mc Ardle, Rosie Morris, Aodhán Hickey, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 22, 2021
Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [11C]PHNO PETEugenii A Rabiner, Tolga Uz, Ayla Mansur, et al.
Imaging Neuroscience (Cambridge, Mass.)|February 24, 2025
The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: A [11C]UCB-J PET and fMRI studyEkaterina Shatalina, Ellis Chika Onwordi, Thomas Whitehurst, et al.
Pageof 25